Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.072 USD | +7.46% | +12.50% | -10.00% |
Jun. 28 | Manulife US REIT Granted Approval to Appoint CEO and CFO | MT |
Jun. 25 | Manulife US REIT Confirms Exemption from US Withholding Tax | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.00% | 128M | B | ||
-3.43% | 10.64B | A- | ||
-5.89% | 6.19B | C | ||
-12.11% | 4.92B | A+ | ||
-11.64% | 4.65B | B- | ||
-11.50% | 4.14B | A- | ||
+11.61% | 4.11B | B | ||
-3.17% | 4.02B | - | ||
-14.73% | 3.77B | B | ||
-4.18% | 3.01B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BTOU Stock
- Ratings Manulife US Real Estate Investment Trust